Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022

BUY
$242.49 - $301.46 $33,706 - $41,902
139 New
139 $34,000
Q2 2021

Aug 13, 2021

SELL
$262.71 - $351.17 $11,296 - $15,100
-43 Closed
0 $0
Q1 2021

May 17, 2021

BUY
$285.92 - $355.13 $12,294 - $15,270
43 New
43 $14,000
Q2 2018

Aug 14, 2018

SELL
$278.07 - $446.21 $6.11 Million - $9.81 Million
-21,989 Closed
0 $0
Q1 2018

May 11, 2018

SELL
$192.49 - $295.85 $1.75 Million - $2.7 Million
-9,112 Reduced 29.3%
21,989 $6.4 Million
Q4 2017

Feb 14, 2018

BUY
$168.78 - $199.74 $423,131 - $500,748
2,507 Added 8.77%
31,101 $5.83 Million
Q3 2017

Nov 14, 2017

BUY
$145.39 - $168.6 $4.16 Million - $4.82 Million
28,594
28,594 $4.82 Million

Others Institutions Holding ABMD

About ABIOMED INC


  • Ticker ABMD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 45,460,900
  • Description
  • Abiomed, Inc. engages in the research, development, and sale of medical devices to assist or replace the pumping function of the failing heart. It also provides a continuum of care to heart failure patients. The company offers Impella 2.5, a percutaneous micro heart pump with integrated motor and sensors; and Impella CP, a device for use by inte...
More about ABMD
Track This Portfolio

Track Loomis Sayles & CO L P Portfolio

Follow Loomis Sayles & CO L P and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Loomis Sayles & CO L P, based on Form 13F filings with the SEC.

News

Stay updated on Loomis Sayles & CO L P with notifications on news.